BCL10 gene mutation in lymphoma

Blood

Volumn 95, Issue 12, 2000, Pages 3885-3890

  Du, Ming Qing ^a   Peng, Huaizheng ^b   Liu, Hongxiang ^b   Hamoudi, Rifat A ^b   Diss, Tim C ^b   Willis, Tony G ^b   Ye, Hongtao ^b   Dogan, Ahmet ^b   Wotherspoon, Andrew C ^b   Dyer, Martin J S ^b   Isaacson, Peter G ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CHROMOSOME 14Q; CHROMOSOME 1P; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034659781     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3885     Document Type: Article

References (26)

1. Willis TG, Jadayel DM, Du MQ, et al. BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:35.
2. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet. 1999;22:63.
3. Koseki T, Inohara N, Chen S, et al. CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to herpesvirus-2 protein E10. J Biol Chem. 1999; 274:9955.
4. Thome M, Martinon F, Hofmann K, et al. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappa B transcription factor and c-Jun N-terminal kinase. J Biol Chem. 1999;274:9962.
5. Yan M, Lee J, Schilbach S, Goddard A, Dixit V. mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem. 1999; 274:10,287.
6. Srinivasula SM, Ahmad M, Lin JH, et al. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappa B activation and apoptosis. J Biol Chem. 1999;274:17,946.
7. Costanzo A, Guiet C, Vito P. c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappa B. J Biol Chem. 1999;274:20,127.
8. Tilly H, Rossi A, Stamatoullas A, et al. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 1994;84:1043.
9. Lee WC, Balsara B, Liu Z, Jhanwar SC, Testa JR. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res. 1996;56:4297.
10. Mathew S, Murty W, Bosl GJ, Chaganti RS. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res. 1994;54:6265.
11. Apostolou S, De Rienzo A, Murthy SS, Jhanwar SC, Testa JR. Absence of BCL10 mutations in human malignant mesothelioma. Cell. 1999;97: 684.
12. Fakruddin JM, Chaganti RS, Murty VV. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell. 1999;97:683.
13. Gill S, Broni J, Jefferies S, et al. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. Br J Cancer. 1999;80:1565.
14. Stone JG, Rowan AJ, Tomlinson IP, Houlston RS. Mutations in BCL10 are very rare in colorectal cancer. Br J Cancer. 1999;80:1569.
15. van Schothorst EM, Mohkamsing S, van Gurp RJ, et al. Lack of BCL10 mutations in testicular germ cell tumors and derived cell lines. Br J Cancer. 1999;80:1571.
16. Lambers AR, Gumbs C, Ali S, et al. BCL10 is not a target for frequent mutation in human carcinomas. Br J Cancer. 1999;80:1575.
17. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575.
18. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both. Blood 1996;87:1255.
19. Wotherspoon AC, Pan LX, Diss TC, Isaacson PG. Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet. 1992;58:35.
20. Pan LX, Diss TC, Peng HZ, Isaacson PG. Clonality analysis of defined B-cell populations in archival tissue sections using microdissection and the polymerase chain reaction. Histopathology. 1994; 24:323.
21. Spencer J, Diss TC, Isaacson PG. Primary B cell gastric lymphoma: a genotypic analysis. Am J Pathol. 1989;135:557.
22. Ye HT, Dogan A, Willis TG, Dyer MJS, Isaacson PG, Du MQ. BCL10 expression in normal and neoplastic lymphoid tissue. J Pathol. 1999; 1895:10a.
23. Ott G, Katzenberger T, Greiner A, et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997;57:3944.
24. van Leauwen FW, Burbach JP, Hol EM. Mutations in RNA: a first example of molecular misreading in Alzheimer's disease. Trends Neurosci. 1998; 21:331.
25. Thiede C, Morgner A, Alpen B, et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology. 1997;113:S61-S64.
26. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 1997;89:1350.